Filing Details

Accession Number:
0001209191-20-002287
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-01-07 16:39:05
Reporting Period:
2020-01-03
Accepted Time:
2020-01-07 16:39:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1419600 Flexion Therapeutics Inc FLXN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1764676 Christina Willwerth C/O Flexion Therapeutics, Inc.
10 Mall Road, Suite 301
Burlington MA 01803
Chief Strategy Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-01-03 3,533 $0.00 52,473 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Sale of shares to cover tax withholding obligations associated with the vesting of restricted stock unit awards granted to the Reporting Person on February 1, 2018 and March 1, 2019.
  2. The shares were sold at a range of prices between $19.71 and $19.89. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  3. Since the date of the Reporting Person's last ownership report, she transferred 10,161 shares of Common Stock of the Issuer to her former spouse pursuant to a domestic relations order.